It starts with a simple wheeze—a tightness in your chest during your morning walk, shortness of breath as you climb the stairs to your apartment. You dismiss it as pollution or a lingering cold, especially if you live in Delhi, Mumbai, or Kolkata where the air quality index (AQI) regularly breaches hazardous levels. But these symptoms may signal the start of asthma or COPD, two chronic respiratory conditions that have become a defining health crisis in India. Today, approximately 37 million Indians suffer from asthma, while India ranks second globally in COPD burden, with over 55 million cases. The culprits? Air pollution, occupational hazards, biomass fuel cooking, tobacco smoke, and seasonal triggers like Diwali fireworks and crop burning. If left undiagnosed, both conditions steal quality of life—and in severe cases, life itself.
This guide equips you and your family with everything needed to understand, diagnose, and manage asthma and COPD in the Indian context—from recognising symptoms to interpreting spirometry reports to using inhalers correctly.
Understanding Asthma vs COPD: Key Differences
While asthma and COPD both involve airway obstruction and breathlessness, they are distinct diseases with different causes, progression, and reversibility.
Asthma
Asthma is a chronic inflammatory condition characterised by reversible airway narrowing. The airways become inflamed and sensitive, producing extra mucus and tightening in response to triggers—allergens, exercise, cold air, infections, or stress.
Key features:
- Symptoms come and go; patients have symptom-free periods
- Airway obstruction is reversible — with treatment (inhalers), breathing returns to normal
- Often starts in childhood, but can develop at any age
- No permanent lung damage if well-controlled
- Caused by allergic and non-allergic triggers
COPD (Chronic Obstructive Pulmonary Disease)
COPD is a progressive, largely irreversible condition caused by long-term exposure to harmful substances—most commonly cigarette smoke or biomass fuel smoke. The lungs lose their elasticity, and the airways are persistently inflamed and narrowed.
Key features:
- Symptoms are persistent and progressive
- Airway obstruction is mostly irreversible — permanent structural damage
- Nearly always starts in adulthood (age 40+)
- Smoking and occupational exposure are the main causes
- Includes emphysema (lung destruction) and chronic bronchitis (persistent cough)
Quick Comparison
| Feature | Asthma | COPD |
|---|---|---|
| Reversibility | Reversible | Mostly irreversible |
| Onset | Often childhood; can be any age | Adults 40+ |
| Triggers | Allergens, exercise, cold, stress | Smoking, biomass fuel, occupational dust |
| Symptoms Pattern | Episodic, symptom-free intervals | Persistent, progressive |
| Lung Damage | None if well-controlled | Permanent |
| Smoking Link | Not the main cause | Primary cause in 80% of cases |
Asthma in India: What's Driving the Crisis?
India's asthma epidemic reflects a perfect storm of environmental, occupational, and lifestyle factors unique to our country.
Why Asthma Is Exploding in India
Air Pollution
India's air quality has become a global scandal. Delhi regularly tops the list of the world's most polluted cities, with PM2.5 (fine particulate matter) levels exceeding WHO recommendations by 10-50 times during winter. Mumbai and Kolkata aren't far behind. Long-term exposure to outdoor air pollution increases asthma risk by 50-200%, and acute pollution spikes trigger asthma attacks in susceptible individuals—a phenomenon clinicians call "pollution-related asthma exacerbation."
During October–November (crop burning season in Punjab and Haryana), air quality deteriorates so severely that respiratory clinics see a 3-4 fold rise in asthma attacks across North India.
Indoor Air Pollution
Over 30% of Indian households still use solid cooking fuels—wood, dung cakes, coal, or kerosene—for cooking. Women and children exposed to this smoke daily have 2-3 times higher asthma risk compared to those using clean fuels (LPG or electric). The smoke contains PM2.5, carbon monoxide, formaldehyde, and benzene—all airway irritants. Additionally, incense sticks (agarbatti), commonly used in Indian homes for prayers, release benzene and formaldehyde; chronic exposure increases asthma risk.
Allergic Triggers
Indian homes harbour high allergen loads:
- Dust mites: Thrive in humid climates and bedding; major asthma trigger
- Cockroaches: Endemic in dense urban housing; their faeces and saliva are potent allergens
- Mould: Monsoons and damp homes create ideal mould conditions
- Pollen: Particularly during spring (March–May) in North India and during specific flowering seasons
- Pet dander: Increasingly common in urban Indian homes
Seasonal and Cultural Triggers
- Diwali fireworks: The post-Diwali spike in respiratory emergencies is well-documented. Fireworks release particulates, heavy metals, and chemical irritants; asthma patients experience severe attacks for days afterward
- Wedding season smoke: Fireworks at weddings (December–February) trigger similar asthma exacerbations
- Occupational exposure: Workers in brick kilns, textile mills, construction sites, and metalwork shops inhale dust and chemicals chronically, developing occupational asthma
Infections and Comorbidities
Respiratory infections (common colds, influenza, pertussis) trigger asthma in susceptible individuals. Additionally, a rising tide of diabetes, obesity, and allergic rhinitis in India increases asthma prevalence and severity.
COPD in India: The Silent Epidemic
If asthma is the visible crisis, COPD is the silent killer—underdiagnosed, underreported, and devastating to families.
The Burden in India
India bears an enormous COPD burden:
- 55+ million COPD cases — second only to China globally
- COPD is the 4th leading cause of death in India (after ischemic heart disease, stroke, and lower respiratory infections)
- Most cases remain undiagnosed; patients don't seek care until advanced stages
- COPD costs India an estimated ₹60,000+ crore annually in lost productivity and healthcare
The disease strikes hardest among the poor and rural populations—those most exposed to biomass smoke and occupational dust.
Why COPD Develops in India
Tobacco and Smoking
India is home to over 26 crore tobacco users. Cigarette smoking causes COPD in 80% of cases; bidis (hand-rolled tobacco leaves) are equally harmful. A 20-year smoker has a 50% lifetime risk of developing COPD.
Biomass Fuel Cooking
Women in rural and low-income urban households cooking over biomass fires (wood, dung, coal) face "indoor smoke" equivalent to smoking 40+ cigarettes daily. An estimated 20 lakh women in India develop COPD from biomass smoke alone—a phenomenon sometimes called "housewife's lung."
Occupational Dust Exposure
Millions of Indian workers face chronic dust exposure:
- Brick kiln workers: Inhale silica dust, fly ash, and wood smoke; prevalence of COPD and emphysema is 40-60% in this population
- Coal miners: Silicosis and coal worker's pneumoconiosis are rampant
- Textile workers: Exposure to cotton dust, dyes, and chemicals
- Construction workers: Silica dust from concrete, stone, and sand
- Agricultural workers: Grain dust, pesticides, and crop-burning smoke
Occupational COPD accounts for an estimated 15-20% of total COPD cases globally; in India, the figure is likely higher due to lax workplace safety standards.
Recurrent Infections
Poverty, malnutrition, and crowded living conditions in India increase respiratory infection rates. Repeated infections (tuberculosis, pneumonia, bronchitis) cause permanent airway scarring and increase COPD risk.
Combination Exposures
Many Indians face multiple simultaneous exposures—a rural woman who cooks over biomass fires, lives with a smoking husband, and is exposed to agricultural dust. This cumulative effect accelerates COPD development.
Symptoms: When to Seek Help
Recognising early symptoms is critical—once COPD develops, lung function cannot be fully restored, but early diagnosis allows interventions to slow progression.
Asthma Symptoms
- Wheezing: A whistling sound when breathing, especially during exertion or at night
- Shortness of breath: Breathlessness during normal activities like climbing stairs or walking briskly
- Chest tightness: Sensation of pressure or heaviness in the chest
- Cough: Often dry, worse at night or with cold air exposure; may produce phlegm during infections
- Symptoms come and go: Patients may have symptom-free periods between attacks
Red flags requiring emergency care:
- Difficulty speaking (severe breathlessness)
- Cyanosis (bluish lips or fingers)
- Peak flow metre reading <50% of personal best
- No improvement with inhalers within 15 minutes
COPD Symptoms
- Persistent cough: Present most days; productive (with phlegm) or dry
- Shortness of breath: Worsens progressively; initially on exertion, later at rest
- Wheezing or whistling sounds
- Frequent respiratory infections: Repeated bronchitis or pneumonia
- Fatigue and weakness
- Leg swelling: In advanced COPD due to heart strain
- Symptoms are relentless: Unlike asthma, they don't remit
Key point: Many Indians (especially in rural areas) dismiss a chronic cough as normal or "smoker's cough" and don't seek care. A persistent cough lasting >3 weeks warrants spirometry.
Pulse Oximetry (SpO2) Readings
Pulse oximetry (SpO2) measures blood oxygen saturation using a simple fingertip device (₹50-200 in India). Normal SpO2 is 95-100%.
- 95-100%: Normal
- 90-94%: Mild hypoxemia; monitor closely
- <90%: Significant hypoxemia; requires medical attention
- <85%: Severe; emergency care needed
Many Indian homes now own pulse oximetres post-COVID. If you experience breathlessness, check your SpO2 and report the reading to your doctor.
Diagnostic Tests for Asthma & COPD in India
Diagnosis requires both clinical assessment and objective testing. Here's what to expect and what each test costs:
Spirometry (Lung Function Test)
What it measures: Spirometry quantifies lung capacity and airflow. Two key values are FEV1 (Forced Expiratory Volume in 1 second) and FVC (Forced Vital Capacity). The ratio FEV1/FVC is diagnostic.
How it's done: You breathe into a tube connected to a spirometer. The machine measures how much air you inhale and exhale, and how quickly.
Normal values:
- FEV1/FVC ratio: >0.70 (70%) in adults
- FEV1: >80% of predicted for age, height, sex
Interpretation for Asthma and COPD:
- FEV1/FVC <0.70 + reversibility (>12% improvement with bronchodilator) = Asthma
- FEV1/FVC <0.70 + limited reversibility = COPD
Cost: ₹500-1,500 (private); free at government hospitals
Pro tip: Spirometry should be performed in a certified lab by a trained technician. Many small clinics lack proper calibration; if possible, get it done at a tertiary centre.
Peak Flow Meter
A handheld device measuring the peak expiratory flow rate (PEFR)—the fastest airflow you can produce.
How it's done: You take a deep breath and blow into the metre as hard as possible. Readings are in litres per minute (L/min).
Normal ranges (PEFR):
- Adult men: 380-760 L/min
- Adult women: 270-460 L/min
- Varies by age, height, and body size
Use: Asthmatics use peak flow metres at home to monitor disease control; a sudden drop indicates worsening asthma.
Cost: ₹100-300 (one-time purchase); very useful for home monitoring
Pulse Oximetry (SpO2)
Measures blood oxygen saturation using a fingertip sensor.
Cost: ₹50-200 (device); ₹100-300 (single test at clinic)
Chest X-Ray
Assesses lung structure; useful to exclude other conditions (pneumonia, TB, lung cancer) and look for emphysema features in COPD.
Cost: ₹300-800 (private); free at government hospitals
High-Resolution CT Chest (HRCT)
Detailed imaging showing emphysema, bronchiectasis, or other structural changes in COPD. More sensitive than chest X-ray but involves higher radiation.
Cost: ₹2,000-5,000 (private)
Allergy Testing
Skin prick test or blood tests (specific IgE) identify allergens triggering asthma.
Cost: ₹500-2,000
Complete Blood Count (CBC) and Sputum Culture
CBC may show elevated eosinophils (>400/μL) in allergic asthma. Sputum culture identifies bacterial pathogens if infection is suspected.
Cost: ₹200-500 (CBC); ₹500-1,500 (sputum culture)
Test Cost Summary
| Test | Purpose | Normal Value | Cost (INR) |
|---|---|---|---|
| Spirometry (FEV1/FVC) | Confirms airflow obstruction; assesses severity | >0.70 (>70%) | ₹500-1,500 |
| Pulse Oximetry (SpO2) | Blood oxygen level | 95-100% | ₹50-200 |
| Peak Flow Metre (PEFR) | Home monitoring of airflow | >80% predicted | ₹100-300 |
| Chest X-Ray | Lung structure; excludes other conditions | Clear fields | ₹300-800 |
| Allergy Testing (Skin Prick) | Identifies allergens | Negative (no wheal) | ₹500-2,000 |
| CBC | Eosinophil count; rules out infection | WBC 4,500-11,000 | ₹200-400 |
Understanding Your Spirometry Report
A spirometry report can look intimidating, but understanding the key parameters helps you and your family manage disease better.
Key Parameters
FEV1 (Forced Expiratory Volume in 1 second)
The volume of air you can forcefully exhale in the first second. Measured in litres and as a percentage of predicted (based on age, height, sex).
- >80% predicted: Normal
- 60-79% predicted: Mild obstruction
- 40-59% predicted: Moderate obstruction
- <40% predicted: Severe obstruction
FVC (Forced Vital Capacity)
Total volume of air you can exhale after a maximum inhalation.
FEV1/FVC Ratio
The ratio of FEV1 to FVC.
- >0.70 (>70%): Normal — no airflow obstruction
- <0.70 (<70%): Airflow obstruction present — suggests asthma or COPD
GOLD Staging for COPD
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classifies COPD severity based on FEV1:
| Stage | FEV1 | Severity |
|---|---|---|
| GOLD 1 | ≥80% predicted | Mild |
| GOLD 2 | 50-79% predicted | Moderate |
| GOLD 3 | 30-49% predicted | Severe |
| GOLD 4 | <30% predicted | Very Severe |
Example: If your FEV1 is 45% predicted and FEV1/FVC is 0.62, you have COPD GOLD Stage 3 (severe).
What Reversibility Means
After the initial spirometry, you inhale a bronchodilator (usually salbutamol) and repeat the test after 15 minutes.
- Increase in FEV1 >12% and >200 mL: Reversible obstruction → suggests asthma
- Little to no change: Irreversible obstruction → suggests COPD
This distinction guides treatment.
Treatment in India: Inhalers, Medications & Breathing Exercises
Managing asthma and COPD relies on medications (inhalers), lifestyle changes, and in the case of asthma, identifying and avoiding triggers.
Asthma Inhalers in India
Inhalers deliver medication directly to the lungs, providing rapid relief and long-term control.
Reliever (Rescue) Inhalers — for acute attacks
| Drug | Brand Names | Dose | Use |
|---|---|---|---|
| Salbutamol (Albuterol) | Asthalin, Budamate, Volisol | 100 mcg/puff | 1-2 puffs every 4-6 hours as needed for wheezing/breathlessness |
Asthalin is the most common and affordable (₹40-80 per inhaler).
Controllers (Preventers) — taken daily
| Drug | Brand Names | Dose | Use |
|---|---|---|---|
| Budesonide (ICS) | Budecort, Budasonide | 100-200 mcg | 1-2 puffs once or twice daily; prevents inflammation |
| Beclomethasone (ICS) | Becasule, Aerobec | 50-100 mcg | Alternative to budesonide |
| Fluticasone (ICS) | Flixotide, Flovent | 110-220 mcg | Stronger ICS; preferred in moderate-severe asthma |
| Combination (ICS + LABA) | Foracort (budesonide + formoterol), Seroflo (fluticasone + salmeterol) | Varies | 1-2 puffs once or twice daily; combines inflammation control + airway relaxation |
Most common controller in India: Foracort (budesonide 100 mcg + formoterol 6 mcg per puff), costing ₹80-150.
COPD Inhalers in India
Bronchodilators
| Drug | Brand Names | Type | Dose | Use |
|---|---|---|---|---|
| Salbutamol | Asthalin | SABA (short-acting) | 100 mcg/puff | Every 4-6 hours as needed |
| Formoterol | Part of Foracort, Formodual | LABA (long-acting) | 6-12 mcg | Once or twice daily |
| Tiotropium | Tiova, Spiriva | LAMA (long-acting) | 18 mcg | Once daily; excellent for COPD maintenance |
| Ipratropium | Aerovent, Inhalant | Anticholinergic | 20 mcg | Every 6 hours or as combination |
Most common for COPD: Tiova (tiotropium) 18 mcg once daily, costing ₹150-300 per inhaler.
Combination Inhalers
| Drug Combination | Brand Names | Use |
|---|---|---|
| LABA + ICS | Foracort, Seroflo | COPD with asthmatic features |
| LABA + LAMA | Anoro (tiotropium + olodaterol) | COPD maintenance |
Inhaler Technique
Incorrect technique is extremely common in India and causes treatment failure. Many patients "puff" into the air rather than into their mouths. Here's the correct method:
- Shake the inhaler 10-15 times to mix the medication
- Exhale completely to empty your lungs
- Place the inhaler mouthpiece between your teeth (not on lips alone) and seal with your lips
- Press and inhale simultaneously — coordinate the button press with a deep, slow inhalation over 3-5 seconds
- Hold your breath for 10 seconds to allow medication to settle in airways
- Wait 1 minute before the next puff if taking multiple puffs
- Rinse your mouth after use to prevent oral thrush (especially with ICS)
Pro tip: Ask your doctor to observe your technique at every visit and correct errors. Many clinics now provide simple "teach-back" videos.
Spacers and Holding Chambers
A spacer is a tube that attaches to your inhaler, making it easier to coordinate breathing and inhaler use. Spacers are particularly helpful for children and elderly patients. Cost: ₹200-500.
Always use a spacer with ICS to prevent oral thrush.
Oral Medications
| Drug | Indication | Brand Names | Cost |
|---|---|---|---|
| Theophylline | Asthma/COPD (if inhalers insufficient) | Theodur, Nuelin, Lasma | ₹30-100 |
| Leukotriene Antagonists (Montelukast) | Asthma (especially allergic/exercise-induced) | Singulair, Montair | ₹15-50 |
| Oral Corticosteroids (Prednisolone) | Asthma exacerbation; acute attacks | Wysolone | ₹10-30 |
Breathing Exercises (Pranayama)
Traditional Indian breathing exercises significantly benefit asthma and COPD patients:
- Diaphragmatic breathing: Breathe slowly and deeply, expanding your belly (not chest). Reduces breathlessness and anxiety
- Pursed-lip breathing: Breathe in through the nose, exhale slowly through pursed lips. Helps COPD patients manage shortness of breath
- Nadi Shodhana (Alternate Nostril Breathing): Balances nervous system; reduces stress-triggered asthma
- Bhramari (Bee Breath): Calming; helpful for asthma triggered by anxiety
Practice 10-15 minutes daily. Many YouTube channels offer guided pranayama for respiratory health (search "pranayama for asthma").
Practical Tips for Managing Asthma in India
Monitor Air Quality
- Check the Air Quality Index (AQI) daily using apps like AirVisual, IQAir, or the Indian government's AQI website
- AQI <50 (Good): Safe for all activities
- AQI 50-100 (Satisfactory): Generally safe
- AQI 100-200 (Moderate to Poor): Vulnerable groups (children, elderly, asthmatics) should limit outdoor activities
- AQI >200 (Very Poor): Stay indoors; use air purifiers and N95 masks if you must go outside
During Pollution Peaks
- Use N95 or N99 masks (₹5-20 per mask) when outdoors
- Install a HEPA air purifier at home (₹5,000-20,000) — effective especially in bedrooms
- Avoid outdoor exercise during peak pollution hours (early morning, evening)
- Keep windows and doors closed when AQI is high
- Run your car's air filtration system during drives in polluted cities
Avoid Diwali Smoke
- Stay indoors during Diwali fireworks (typically 8-11 PM on Diwali night and surrounding days)
- Close windows and doors; run indoor air purifiers
- Use N95 masks if you must venture outdoors
- Keep rescue inhalers readily accessible during the Diwali period — many asthmatics experience attacks
- Encourage alternatives: Opt for "green Diwali"—burst fewer fireworks or switch to lighting diyas and electronic displays
Use Agarbatti Wisely
- Limit incense stick use or switch to fragrant flowers and plants
- Use inhalers preventively if you burn incense regularly
- Ensure good ventilation when using agarbatti
Manage Occupational Exposure
If you work in a high-dust environment (brick kiln, textile, construction, mining):
- Wear respiratory protection: N95 masks or powered air-purifying respirators (PAPRs)
- Use masks consistently — not just occasionally
- Advocate for workplace safety: Support union efforts for proper ventilation, dust suppression, and health monitoring
- Get regular spirometry: Early detection allows intervention before permanent damage
Trigger Avoidance and Control
- Identify your triggers: Keep a symptom diary noting what precedes attacks (weather changes, allergens, infections, stress)
- Avoid identified triggers: If cockroaches trigger asthma, maintain cleanliness and use appropriate pest control
- Manage allergic rhinitis: Postnasal drip worsens asthma; treat with nasal antihistamines or corticosteroid sprays
- Control infections: Promptly treat colds, flu, and other respiratory infections to prevent asthma complications
- Stress management: Stress and anxiety trigger asthma; practice relaxation techniques, yoga, or meditation
Regular Follow-Up
- See your doctor every 1-3 months (more often if poorly controlled)
- Use a peak flow metre at home; record readings daily
- Review inhaler technique at every visit
- Adjust medications as needed based on control level
- Discuss asthma action plan: Your doctor should provide a written plan for managing mild, moderate, and severe attacks
Practical Tips for Managing COPD in India
Smoking Cessation (Absolute Priority)
If you smoke, quitting is the single most impactful intervention. Continued smoking accelerates lung function decline by 10-15 years.
- Nicotine replacement therapy: Patches, gum, lozenges (over-the-counter or prescribed)
- Prescription medications: Varenicline (Champix) or bupropion reduce cravings
- Counselling: Many government health centres and NGOs offer free smoking cessation support
- Mobile apps: Quit India app (free, government) helps track progress
Manage Exposure
- Quit smoking yourself and avoid secondhand smoke
- Switch from biomass fuels to LPG if cooking over wood/dung fires; under Pradhan Mantri Ujjwala Yojana, eligible families receive free LPG connections
- Use exhaust fans or chimneys during cooking
- Use respiratory protection (N95) in occupational settings
Medication Adherence
COPD medications are maintenance therapies taken daily even when feeling well.
- Use long-acting inhalers (Tiova, Anoro) for consistent disease control
- Set reminders on your phone for daily medications
- Use a pill organiser or medicine box for multiple medications
- Ask your doctor for affordable generic alternatives — many are available in India
Pulmonary Rehabilitation
Structured programmes including exercise, breathing techniques, and education improve quality of life and reduce hospital admissions.
- Duration: 6-8 weeks, 2-3 sessions per week
- Components: Aerobic exercise (treadmill, cycling), strength training, breathing exercises, education
- Availability: Major hospitals and government tertiary centres offer pulmonary rehab
- Cost: ₹10,000-50,000 for full programme (may be covered by insurance or government schemes)
Vaccination
- Pneumococcal vaccine (Prevenar 13): Once in lifetime for COPD patients; costs ₹2,500-4,500
- Influenza vaccine: Annual (₹800-1,500); prevents secondary pneumonia
- COVID-19 vaccine: Ensure up-to-date to prevent severe infection
Oxygen Therapy
For advanced COPD with SpO2 <88% at rest or during exertion, oxygen is prescribed.
- Oxygen concentrator (at home): ₹30,000-80,000 one-time; costs ₹5,000-10,000 annually for electricity
- Oxygen cylinders (portable): ₹100-200 per fill; cumbersome but portable
- Liquid oxygen (less common in India): More expensive
Nutrition and Supplements
- Maintain adequate protein intake to preserve muscle mass
- Vitamin D supplementation: Deficiency is common in India; take 1,000-2,000 IU daily
- Avoid weight extremes: Both obesity and low BMI worsen outcomes
- Limit salt: COPD patients often develop cor pulmonale (heart strain); low salt helps
Mental Health
COPD increases depression and anxiety risk. Emotional support is essential:
- Counselling: Speak with a psychologist or counsellor
- Support groups: Connect with other COPD patients (many exist in major Indian cities)
- Stress reduction: Meditation, yoga, or relaxation techniques
Asthma in Special Populations
Occupational Asthma in India
Millions of Indian workers develop asthma from workplace exposures—a largely preventable tragedy.
High-risk occupations:
- Brick kiln workers (silica dust, fly ash)
- Textile workers (cotton dust, dyes)
- Metalworkers (metal fumes, welding smoke)
- Flour millers and grain workers (grain dust, mould spores)
- Laboratory workers (chemical vapours, animal proteins)
Prevention and management:
- Identify the trigger substance through occupational history
- Use respiratory protection (N95, respirator, supplied air) — mandatory by law
- Advocate for workplace improvements: Ventilation, dust suppression, health monitoring
- Early diagnosis and removal from exposure can halt progression
- Compensation: Workers are often entitled to compensation under occupational health schemes (varies by state)
Asthma in Pregnancy
Pregnancy affects asthma unpredictably—some improve, others worsen. Untreated asthma poses risks to mother and baby.
Safe medications in pregnancy:
- Inhalers (ICS, LABA): Very safe; no evidence of birth defects
- Salbutamol (rescue): Safe; use as needed
- Prednisolone (oral): Safe in short bursts for exacerbations
- Leukotriene antagonists: Generally safe (consult doctor)
Avoid: Avoid some older medications; ask your obstetrician and pulmonologist
Management: Continue asthma control medications; uncontrolled asthma worsens pregnancy outcomes more than medications do.
When to Seek Emergency Care
Visit the emergency department immediately if you experience:
- Severe breathlessness at rest or inability to speak full sentences
- Cyanosis: Bluish discolouration of lips, fingers, or tongue
- Confusion or difficulty staying alert
- Rapid heart rate >120 bpm or chest pain
- Peak flow <50% of personal best (asthma) with no improvement after 15 minutes of inhalers
- SpO2 <85%
- Inability to use inhalers effectively (incoordination, severe distress)
Pro tip: Keep your rescue inhaler (salbutamol) with you always. If you use it more than twice a week, your asthma is not well-controlled—see your doctor.
Tracking Your Health with Technology
Digital health tools are transforming disease management in India:
- Upload spirometry reports and chest X-rays to MedicalVault — securely store all respiratory tests in one place
- Use MedicalVault's family sharing feature to coordinate care with family members (especially important if managing aging parents' or children's respiratory health)
- Track medication adherence: Log when you take your inhalers; patterns help your doctor assess control
- Monitor peak flow: Record daily readings; share trends with your doctor
- Log asthma triggers: Note symptom patterns to identify and avoid triggers more effectively
Key Takeaways
- India's asthma and COPD epidemics are driven by air pollution, occupational exposure, biomass fuel cooking, and tobacco use—factors uniquely prevalent in our country
- Asthma is reversible; COPD is largely irreversible—early diagnosis of both allows interventions to improve quality of life
- Spirometry is the gold standard diagnostic test; understand your FEV1/FVC ratio and GOLD stage if you have COPD
- Inhalers are the cornerstone of treatment; correct technique is critical and often needs guided practice
- Diwali fireworks, crop burning, agarbatti use, and air pollution are major asthma triggers in India—take preventive measures during high-risk periods
- Smoking cessation is the most impactful intervention for COPD; occupational protection can prevent occupational asthma
- Pulmonary rehabilitation, pulmonary vaccines, and emotional support significantly improve outcomes in COPD
- Track your health digitally: Upload your spirometry, X-rays, and peak flow readings to MedicalVault and use family sharing to coordinate care—a comprehensive, organised health record enables better doctor-patient communication and faster response to changes